Krishna V. Komanduri, MD; David Maloney, MD, PhD; Stephen J. Schuster, MD; and Michael Pulsipher, MD, discuss the potential for allogeneic CAR T-cell approaches for non-Hodgkin’s lymphoma and whether CAR T cells could replace allogeneic stem cell transplant.